AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma
AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma
The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in
 a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled
 persistent asthma, ages 12-15 years, and a caregiver
Inclusion Criteria:

 -  adolescent is 12-15 years old

 -  caregiver is between 18-70 years-old

 -  adolescent lives in the residence of caregiver

 -  adolescent has a physician-verified persistent asthma diagnosis and an active inhaled
 corticosteroid prescription for ≥ 6 months

 -  adolescent poorly controlled asthma (score of ≤ 19 on the Asthma Control Test)

 -  Endorsing one or more symptoms of poorly controlled asthma according to national
 guidelines on more than four separate days in the past two weeks:

 1. Use of any short-acting beta agonist (e.g., quick relief) medication to relieve
 asthma symptoms

 2. Experiencing specific asthma symptoms (i.e., wheezing, tightness of chest,
 coughing) during the day or night

 3. Nighttime awakening 1 or more times per week due to asthma symptoms

 4. Activity limitation due to asthma

 5. 2 or more exacerbations requiring oral systemic corticosteroids in the past year

 6. 2 or more ED visits or one hospitalization in the past year

 7. 2 or more urgent medical care visits due to asthma in the past year

 -  adolescent and caregiver speak and read English.

 Exclusion Criteria:

 -  Family is currently involved in an asthma management intervention above and beyond
 usual care, or

 -  Adolescent has a significant developmental delay that would preclude participation.